The impact of the number of CD34+ cells infused on the hematologic recovery after autologous peripheral blood stem cell (PBSC) transplantation.

被引：0
|
作者：
Palomera, L
Azaceta, G
Varo, MJ
Moreno, JA
Olave, T
Domingo, JM
Mayordomo, JI
Gutiérrez, M
机构：
[1] Clin Hosp, Dept Hematol, Zaragoza, Spain
[2] Clin Hosp, Dept Oncol, Zaragoza, Spain
来源：
BLOOD | 1998年 / 92卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4310
引用
收藏
页码：304B / 304B
页数：1
相关论文
共 50 条
  • [31] Transplantation of positively selected autologous blood CD34+ progenitor cells or unmanipulated PBSC - Comparison of haematologic recovery
    Nemet, D
    Batinic, D
    Uzarevic, B
    Skodlar, J
    Petrovecki, M
    Bogdanic, V
    Mrsic, M
    Maravic, N
    Sucic, M
    Golubic, B
    Bojanic, I
    Kalenic, S
    Labar, B
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 929 - 929
  • [32] High CD34+ cell counts decrease hematologic toxicity of autologous peripheral blood progenitor cell transplantation
    Ketterer, N
    Salles, G
    Raba, M
    Espinouse, D
    Sonet, A
    Tremisi, P
    Dumontet, C
    Moullet, I
    Eljaafari-Corbin, A
    Neidhardt-Berard, EM
    Bouafia, F
    Coiffier, B
    BLOOD, 1998, 91 (09) : 3148 - 3155
  • [33] CD34 cell dose influences hematological recovery after peripheral blood stem cell transplantation.
    Ilhan, O
    Beksac, M
    Arslan, O
    Akan, H
    Koc, H
    Dilek, I
    Arat, M
    Ozcan, M
    Gurman, G
    Konuk, N
    Uysal, A
    BLOOD, 1996, 88 (10) : 3751 - 3751
  • [34] Molecular remission in adult T cell leukemia after autologous CD34+ peripheral blood stem cell transplantation
    M Nakane
    K Ohashi
    Y Sato
    A Moriya
    T Inoue
    S Mori
    S Tanikawa
    H Akiyama
    Y Maeda
    T Sasaki
    K Karasawa
    Y Okuyama
    K Hiruma
    H Sakamaki
    Bone Marrow Transplantation, 1999, 24 : 219 - 221
  • [35] CD34+ cell dose predicts costs after autologous peripheral blood stem cell transplantation for breast cancer
    Baron, F
    Copizza, S
    Baudoux, E
    Jerusalem, G
    Fillet, G
    Beguin, Y
    HAEMATOLOGICA, 2004, 89 (09) : 1146 - 1148
  • [36] Molecular remission in adult T cell leukemia after autologous CD34+ peripheral blood stem cell transplantation
    Nakane, M
    Ohashi, K
    Sato, Y
    Moriya, A
    Inoue, T
    Mori, S
    Tanikawa, S
    Akiyama, H
    Maeda, Y
    Sasaki, T
    Karasawa, K
    Okuyama, Y
    Hiruma, K
    Sakamaki, H
    BONE MARROW TRANSPLANTATION, 1999, 24 (02) : 219 - 221
  • [37] The clearance of CD34+ cells from peripheral blood (PB) after peripheral blood hematopoietic stem cell (PBHSC) infusion is correlated with the hematologic recovery (HR).
    DHondt, L
    Andree, M
    Wuu, J
    vanLerberghe, C
    Guillaume, T
    Feyens, AM
    Dromelet, A
    Chatelain, B
    Humblet, Y
    Longueville, J
    Symann, M
    BLOOD, 1997, 90 (10) : 4355 - 4355
  • [38] CD34+selected autologous peripheral blood stem cell transplantation (CD34+/ASCT) for multiple sclerosis
    Carreras, E
    Saiz, A
    Marín, P
    Martínez, C
    Rovira, M
    Villamor, N
    Aymerich, M
    Lozano, M
    Fernández-Avilés, F
    Urbano-Ispizua, A
    Berenguer, J
    Arbizu, T
    Montserrat, E
    Graus, F
    BONE MARROW TRANSPLANTATION, 2003, 31 : S16 - S16
  • [39] Autologous CD34+selected peripheral blood stem cell transplantation (CD34+/PBSCT) for multiple sclerosis
    Carreras, E
    Saiz, A
    Graus, F
    Marín, P
    Martínez, C
    Rovira, M
    Urbano-Ispizua, A
    Arbizu, T
    Casanova, B
    Mercader, JM
    Mazzara, R
    Merino, A
    Tolosa, E
    Montserrat, E
    BLOOD, 1999, 94 (10) : 398B - 398B
  • [40] Factors affecting hematopoietic engraftment after peripheral blood stem cell transplantation with sufficient number of CD34 (+) cells infused
    Komurcu, S
    Arpaci, F
    Ozet, A
    Ozturk, B
    Arslan, O
    Beyzadeoglu, M
    Hamzaoglu, O
    Yalcin, A
    Beksac, M
    Koc, H
    EXPERIMENTAL HEMATOLOGY, 1997, 25 (08) : 309 - 309
12345